Lisa Zimmer - Concepedia

Author

Lisa Zimmer

Also Known As

L Zimmer, L. Zimmer, Lisa Zimmer, Lisa Zimmer (486043), Lucas G. Zimmer, Luiz Gustavo Cambruzzi Zimmer, Mirjana Ziemer, Yasuhiro Fujisawa, Zimmer, L., Zimmer, Lisa

376

Publications

20.3K

Citations

H-Index

104

Concepts

All Affiliations

Heidelberg University University Hospital Heidelberg Essen University Hospital University of Duisburg-Essen German Cancer Research Center

About

Lisa Zimmer is an author at Heidelberg University specializing in medicine, immunology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	36	69	13.1K
2	Health Sciences	5	5	190
3	Allergy	2	2	132
4	Engineering	1	1	927
5	Social Sciences	1	1	18

Lisa Zimmer

138

Publications

17.6K

Citations

H-Index

Page 1

	Year	Citations
Genomic Classification of Cutaneous Melanoma Rehan Akbani, Kadir C. Akdemir, Bülent Arman Aksoy, Cell Dermoscopic ImageSkin CancerMedicineMelanomaPathology	2015	3.2K
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma Eliezer M. Van Allen, Diana Miao, Bastian Schilling, Science Immune EvasionCancer ImmunosurveillanceImmune Checkpoint ActivityMedicineMelanoma	2015	2.9K
Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma David Liu, Bastian Schilling, Derek Liu, Nature Medicine	2019	1K
The Genetic Landscape of Clinical Resistance to RAF Inhibition in Metastatic Melanoma Eliezer M. Van Allen, Nikhil Wagle, Antje Sucker, Cancer Discovery EngineeringRaf Kinase InhibitorsPathologyCancer BiologyTumor Biology	2013	927
Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial Georgina V. Long, Uwe Trefzer, Michael A. Davies, The Lancet Oncology MedicineMelanomaPathologyVal600lys Braf-mutant MelanomaNeurology	2012	901
Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy Lars Hofmann, Andrea Forschner, Carmen Loquai, European Journal of Cancer UrologyHepatologyAnti-pd-1 TherapyGastrointestinal PharmacologyLiver Physiology	2016	638
Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy Lisa Zimmer, Simone M. Goldinger, Lars Hofmann, European Journal of Cancer Translational MedicineHeart FailureCardiovascular DiseaseAnti-pd-1 TherapyMedicine	2016	552
Phase II DeCOG-Study of Ipilimumab in Pretreated and Treatment-Naïve Patients with Metastatic Uveal Melanoma Lisa Zimmer, Julia Vaübel, Peter Mohr, PLoS ONE	2015	286
TERT Promoter Mutation Status as an Independent Prognostic Factor in Cutaneous Melanoma Klaus Griewank, Rajmohan Murali, Joan Anton Puig‐Butillé, JNCI Journal of the National Cancer Institute	2014	251
Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): a randomised, double-blind, placebo-controlled, phase 2 trial Lisa Zimmer, Elisabeth Livingstone, Jessica C. Hassel, The Lancet Surgical OncologyOncologyMelanomaImmunologyClinical Trials	2020	238

Page 1